Synaptogenix logo

Synaptogenix share price today

(SNPX)

Synaptogenix share price is $3.9 & ₹334.66 as on 7 Jan 2025, 2.30 'hrs' IST

$3.9

0.21

(5.69%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Synaptogenix share price in Dollar and Rupees. Guide to invest in Synaptogenix stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Synaptogenix, along with analyst recommendations, forecasts, and comprehensive financials.

Synaptogenix share price movements

  • Today's Low: $3.53
    Today's High: $3.90

    Day's Volatility :9.52%

  • 52 Weeks Low: $2.32
    52 Weeks High: $7.22

    52 Weeks Volatility :67.88%

Synaptogenix Returns

PeriodSynaptogenix IncIndex (Russel 2000)
3 Months
24.25%
0.0%
6 Months
-18.0%
0.0%
1 Year
-40.89%
0.0%
3 Years
-59.32%
-19.8%

Synaptogenix Key Statistics

in dollars & INR

Previous Close
$3.6901
Open
$3.78
Today's High
$3.9
Today's Low
$3.5289
Market Capitalization
$4.1M
Today's Volume
$30.4K
52 Week High
$7.2225
52 Week Low
$2.32
Revenue TTM
$0.0
EBITDA
$-6.8M
Earnings Per Share (EPS)
$10.27
PE Ratio
0.29
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-7.5%

How to invest in Synaptogenix from India?

It is very easy for Indian residents to invest directly in Synaptogenix from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Synaptogenix stock in both Indian Rupees (INR) and US Dollars (USD). Search for Synaptogenix or SNPX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Synaptogenix or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Synaptogenix shares which would translate to 0.220 fractional shares of Synaptogenix as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Synaptogenix, in just a few clicks!

Returns in Synaptogenix for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Synaptogenix investment value today

Current value as on today

₹65,723

Returns

₹34,277

(-34.28%)

Returns from Synaptogenix Stock

₹37,500 (-37.5%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Synaptogenix

100%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Synaptogenix on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 100% more investors are searching Synaptogenix in the last 30 days versus the previous period.

Global Institutional Holdings in Synaptogenix

  • Tower Research Capital LLC

    0.09%

  • UBS Group AG

    0.08%

  • Morgan Stanley - Brokerage Accounts

    0.01%

Analyst Recommendation on Synaptogenix

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Synaptogenix(by analysts ranked 0 to 5 stars)

Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
3
3
3
Sell
3
3
3

Analyst Forecast on Synaptogenix

What analysts predicted

Upside of 258.97%

Current:

$3.90

Target:

$14.00

Insights on Synaptogenix

  • Price Movement

    In the last 1 month, SNPX stock has moved up by 29.9%
  • SNPX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 66.6%
  • SNPX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 113.1%

Synaptogenix Technicals Summary

Sell

Neutral

Buy

Synaptogenix is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Synaptogenix Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Synaptogenix Inc
27.24%
-18.0%
-40.89%
-59.32%
-46.13%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Synaptogenix Inc
0.29
0.29
NA
-7.48
-0.07
-0.14
NA
14.99
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Synaptogenix Inc
Sell
$4.1M
-46.13%
0.29
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Synaptogenix

synaptogenix is a clinical-stage biopharmaceutical company that has historically worked to develop novel therapies for neurodegenerative diseases.
Organization
Synaptogenix
Employees
5
CEO
Dr. Alan J. Tuchman M.D., MBA(FAAN)
Industry
Miscellaneous

Management People of Synaptogenix

NameTitle
Dr. Alan J. Tuchman M.D., MBA(FAAN)
CEO & Director
Dr. Daniel L. Alkon M.D.
President, Chief Scientific Officer & Director
Mr. Robert Weinstein
CFO, Executive VP, Treasurer & Secretary

Important FAQs about investing in Synaptogenix from India :

What is Synaptogenix share price today?

Synaptogenix share price today stands at $3.90, Open: $3.78 ; Previous Close: $3.69 ; High: $3.90 ; Low: $3.53 ; 52 Week High: $7.22 ; 52 Week Low: $2.32. The stock opens at $3.78, after a previous close of $3.69. The stock reached a daily high of $3.90 and a low of $3.53, with a 52-week high of $7.22 and a 52-week low of $2.32.

Can Indians buy Synaptogenix shares?

Yes, Indians can invest in the Synaptogenix (SNPX) from India.

With INDmoney, you can buy Synaptogenix at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Synaptogenix at zero transaction cost.

How can I buy Synaptogenix shares from India?

It is very easy to buy Synaptogenix from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Synaptogenix be purchased?

Yes, you can buy fractional shares of Synaptogenix with INDmoney app.

What are the documents required to start investing in Synaptogenix stocks?

To start investing in Synaptogenix, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Synaptogenix

Today’s highest price of Synaptogenix (SNPX) is $3.90.

Today’s lowest price of Synaptogenix (SNPX) is $3.53.

What is today's market capitalisation of Synaptogenix

Today's market capitalisation of Synaptogenix SNPX is 4.1M

What is the 52 Week High and Low Range of Synaptogenix

  • 52 Week High

    $7.22

  • 52 Week Low

    $2.32

What are the historical returns of Synaptogenix?

  • 1 Month Returns

    27.24%

  • 3 Months Returns

    -18%

  • 1 Year Returns

    -40.89%

  • 5 Years Returns

    -46.13%

Who is the Chief Executive Officer (CEO) of Synaptogenix

Dr. Alan J. Tuchman M.D., MBA(FAAN) is the current Chief Executive Officer (CEO) of Synaptogenix.